The integration of omics: A promising approach to personalized tuberculosis treatment
Authors:
- Priyanka GuhaPGPriyanka Guha
- Siddhartha DuttaSDSiddhartha Dutta
- Krishna MurtiKMKrishna Murti
- Jay Karan CharanJCJay Karan Charan
- Krishna PandeyKPKrishna Pandey
- V. RavichandiranVRV. Ravichandiran
- Sameer DhingraSDSameer Dhingra
Open Access
- 13 January 2024
- journal article
- review article
- Published by Elsevier in Medicine in Omics
- Vol. 12
Abstract
No abstract availableKeywords
This publication has 101 references indexed in Scilit:
- Metformin as adjunct antituberculosis therapyScience Translational Medicine, 2014
- Host-directed therapy of tuberculosis based on interleukin-1 and type I interferon crosstalkNature, 2014
- Aptamer-based proteomic signature of intensive phase treatment response in pulmonary tuberculosisTuberculosis, 2014
- Statin Therapy Reduces the Mycobacterium tuberculosis Burden in Human Macrophages and in Mice by Enhancing Autophagy and Phagosome MaturationThe Journal of Infectious Diseases, 2013
- Multiple populations of artemisinin-resistant Plasmodium falciparum in CambodiaNature Genetics, 2013
- TNF Dually Mediates Resistance and Susceptibility to Mycobacteria via Mitochondrial Reactive Oxygen SpeciesCell, 2013
- Corticosteroids for prevention of mortality in people with tuberculosis: a systematic review and meta-analysisThe Lancet Infectious Diseases, 2013
- Relapse of tuberculosis versus primary tuberculosis; course, pathogenesis and therapy in miceTuberculosis, 2013
- Abelson Tyrosine Kinase Controls Phagosomal Acidification Required for Killing of Mycobacterium tuberculosis in Human MacrophagesThe Journal of Immunology, 2012
- Distinct Phases of Blood Gene Expression Pattern Through Tuberculosis Treatment Reflect Modulation of the Humoral Immune ResponseThe Journal of Infectious Diseases, 2012